Acquirer(s)
- Johnson & Johnson Inc
Target(s)
- Pfizer Inc
Summary
Johnson & Johnson - proposed acquisition of Pfizer Inc's consumer healthcare businessMarket definition
The proposed acquisition was considered in relation to the supply in Australia of:1. worm treatments;
2. anti-diarrhoeals; and
2. nicotine replacement therapy products.
Competition analysis
The ACCC decided not to oppose the proposed acquisition subject to section 87B undertakings being provided by Johnson & Johnson and Pfizer Inc. The reasons for the ACCC's decision are set out in the Public Competition Assessment relating to this matter.Statement of issues
Document title | Date | |
---|---|---|
Statement of Issues. |
Public competition assessment
Document title | Date | |
---|---|---|
Public Competition Assessment. |
Undertakings
Document title | Date | |
---|---|---|
Final Pfizer Inc 87B Undertakings | ||
Final Johnson & Johnson 87B Undertakings |
Timeline
Date | Event |
---|---|
ACCC received submission from Johnson & Johnson. ACCC commences review under the Merger Review Process Guidelines. Market inquiries commence. |
|
ACCC requested further information from Johnson & Johnson. Indicative timeline suspended pending receipt of Johnson & Johnson's response. |
|
ACCC received Johnson & Johnson's response to ACCC information request of 11 October. |
|
Johnson & Johnson advised intention to make submission to ACCC addressing possible competition effects. |
|
Closing date for submissions from interested parties. |
|
ACCC received submission from Johnson & Johnson addressing possible competition effects. |
|
Proposed date for announcement of ACCC's findings (30 November 2006) delayed pending the resolution of Applicant's claim for confidentiality and related matters. |
|
Applicant's claim for confidentiality and related matters resolved. ACCC timeline recommenced. |
|
ACCC published Statement of Issues outlining its preliminary competition concerns. |
|
Closing date for submissions from interested parties responding to ACCC's Statement of Issues. |
|
Johnson & Johnson submitted s.87B Undertaking relating to its divestiture proposal for market inquiries by ACCC, and ACCC commenced market inquiries on Johnson & Johnson's proposed divestiture. |
|
Closing date for submissions from interested parties regarding Johnson & Johnson's proposed divestiture. |
|
ACCC accepted section 87B undertakings from Johnson & Johnson and Pfizer and announced it will not oppose the proposed acquisition. |